STAR Protocols (Dec 2021)

Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein

  • Chao Wu,
  • Abraham J. Qavi,
  • Austin B. Moyle,
  • Nicole D. Wagner,
  • Asmaa Hachim,
  • Niloufar Kavian,
  • Aidan R. Cole,
  • Joyce Sweeney-Gibbons,
  • Henry W. Rohrs,
  • J.S. Malik Peiris,
  • Christopher F. Basler,
  • Michael L. Gross,
  • Sophie A. Valkenburg,
  • Christopher W. Farnsworth,
  • Gaya K. Amarasinghe,
  • Daisy W. Leung

Journal volume & issue
Vol. 2, no. 4
p. 100906

Abstract

Read online

Summary: Nucleocapsid proteins are essential for SARS-CoV-2 life cycle. Here, we describe protocols to gather domain-specific insights about essential properties of nucleocapsids. These assays include dynamic light scattering to characterize oligomerization, fluorescence polarization to quantify RNA binding, hydrogen-deuterium exchange mass spectrometry to map RNA binding regions, negative-stain electron microscopy to visualize oligomeric species, interferon reporter assay to evaluate interferon signaling modulation, and a serology assay to reveal insights for improved sensitivity and specificity. These assays are broadly applicable to RNA-encapsidated nucleocapsids.For complete details on the use and execution of this protocol, please refer to Wu et al. (2021).

Keywords